These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25340550)

  • 1. Pterocarpanquinone LQB-118 induces apoptosis in Leishmania (Viannia) braziliensis and controls lesions in infected hamsters.
    Costa L; Pinheiro RO; Dutra PM; Santos RF; Cunha-Júnior EF; Torres-Santos EC; da Silva AJ; Costa PR; Da-Silva SA
    PLoS One; 2014; 9(10):e109672. PubMed ID: 25340550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LQB-118, an orally active pterocarpanquinone, induces selective oxidative stress and apoptosis in Leishmania amazonensis.
    Ribeiro GA; Cunha-Júnior EF; Pinheiro RO; da-Silva SA; Canto-Cavalheiro MM; da Silva AJ; Costa PR; Netto CD; Melo RC; Almeida-Amaral EE; Torres-Santos EC
    J Antimicrob Chemother; 2013 Apr; 68(4):789-99. PubMed ID: 23288404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low doses of 3-phenyl-lawsone or meglumine antimoniate delivery by tattooing route are successful in reducing parasite load in cutaneous lesions of
    Meira RMV; Gomes SLDS; Schaeffer E; Da Silva T; Brito ACS; Siqueira LM; Inácio JD; Almeida-Amaral EE; Da-Cruz AM; Bezerra-Paiva M; Neves RH; Rodrigues LS; Dutra PML; Costa PRR; da Silva AJM; Da-Silva SAG
    Front Cell Infect Microbiol; 2023; 13():1025359. PubMed ID: 36743305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the local or oral delivery of the novel naphthopterocarpanquinone LQB-118 against cutaneous leishmaniasis.
    da Cunha-Júnior EF; Pacienza-Lima W; Ribeiro GA; Netto CD; do Canto-Cavalheiro MM; da Silva AJ; Costa PR; Rossi-Bergmann B; Torres-Santos EC
    J Antimicrob Chemother; 2011 Jul; 66(7):1555-9. PubMed ID: 21531758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
    Bezerra-Souza A; Yamamoto ES; Laurenti MD; Ribeiro SP; Passero LF
    Parasitol Int; 2016 Dec; 65(6 Pt A):702-707. PubMed ID: 27546158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
    de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
    Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis.
    Ribeiro-Romão RP; Saavedra AF; Da-Cruz AM; Pinto EF; Moreira OC
    Parasit Vectors; 2016 Jun; 9(1):361. PubMed ID: 27350537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alkylaminoalkanethiosulfuric acids exhibit in-vitro antileishmanial activity against Leishmania (Viannia) braziliensis: a new perspective for use of these schistosomicidal agents.
    Porcino GN; Antinarelli LMR; Maia ACRG; Faria-Pinto P; Taunay-Rodrigues A; Zech Coelho PM; Nelson DL; Penido MLO; Coimbra ES; Vasconcelos EG
    J Pharm Pharmacol; 2019 Dec; 71(12):1784-1791. PubMed ID: 31579947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
    J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of oral quercetin in hamsters infected with
    Dos Santos RF; Da Silva T; Brito ACS; Inácio JD; Ventura BD; Mendes MAP; Azevedo BF; Siqueira LM; Almeida-Amaral EE; Dutra PML; Da-Silva SAG
    Front Cell Infect Microbiol; 2022; 12():1059168. PubMed ID: 36710981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions.
    Rugani JN; Quaresma PF; Gontijo CF; Soares RP; Monte-Neto RL
    Biomed Pharmacother; 2018 Dec; 108():1170-1180. PubMed ID: 30372818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp.
    Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES
    Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B.
    Shadab M; Jha B; Asad M; Deepthi M; Kamran M; Ali N
    PLoS One; 2017; 12(2):e0171306. PubMed ID: 28170432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Golden hamster (Mesocricetus auratus) as an experimental model for Leishmania (Viannia) braziliensis infection.
    Gomes-Silva A; Valverde JG; Ribeiro-Romão RP; Plácido-Pereira RM; Da-Cruz AM
    Parasitology; 2013 May; 140(6):771-9. PubMed ID: 23369503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome.
    Coelho AC; Oliveira JC; Espada CR; Reimão JQ; Trinconi CT; Uliana SR
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004660. PubMed ID: 27144739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antileismanial activity, mechanism of action study and molecular docking of 1,4-bis(substituted benzalhydrazino)phthalazines.
    Romero AH; Rodríguez N; Oviedo H; Lopez SE
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800299. PubMed ID: 31012160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model.
    Sinagra A; Luna C; Abraham D; Iannella Mdel C; Riarte A; Krolewiecki AJ
    Rev Soc Bras Med Trop; 2007; 40(6):627-30. PubMed ID: 18200413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Studies Evaluating Subacute Toxicity and Therapeutic Efficacy of LQB-118 in Experimental Visceral Leishmaniasis.
    Cunha-Júnior EF; Martins TM; Canto-Cavalheiro MM; Marques PR; Portari EA; Coelho MG; Netto CD; Costa PR; Sabino KC; Torres-Santos EC
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3794-801. PubMed ID: 27067332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morita-Baylis-Hillman adduct shows in vitro activity against Leishmania (Viannia) braziliensis associated with a reduction in IL-6 and IL-10 but independent of nitric oxide.
    Amorim FM; Rodrigues YK; Barbosa TP; Néris PL; Caldas JP; Sousa SC; Leite JA; Rodrigues-Mascarenhas S; Vasconcellos ML; Oliveira MR
    Parasitology; 2013 Jan; 140(1):29-38. PubMed ID: 22906971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.